CID 16073757

3-quinolinecarboxylic acid, 7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-3-methyl-1-piperazinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-

Structural Information

Molecular Formula
C21H23FN6O6S2
SMILES
CC1CN(CCN1S(=O)(=O)C2=NN=C(S2)N)C3=C(C=C4C(=C3OC)N(C=C(C4=O)C(=O)O)C5CC5)F
InChI
InChI=1S/C21H23FN6O6S2/c1-10-8-26(5-6-28(10)36(32,33)21-25-24-20(23)35-21)16-14(22)7-12-15(18(16)34-2)27(11-3-4-11)9-13(17(12)29)19(30)31/h7,9-11H,3-6,8H2,1-2H3,(H2,23,24)(H,30,31)
InChIKey
ZMJSPSHFSJVVKY-UHFFFAOYSA-N
Compound name
7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-3-methylpiperazin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

538.1105 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 539.11778 222.8
[M+Na]+ 561.09972 233.0
[M-H]- 537.10322 227.3
[M+NH4]+ 556.14432 219.7
[M+K]+ 577.07366 223.2
[M+H-H2O]+ 521.10776 215.6
[M+HCOO]- 583.10870 225.1
[M+CH3COO]- 597.12435 227.4
[M+Na-2H]- 559.08517 219.4
[M]+ 538.10995 228.6
[M]- 538.11105 228.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.